Conversion and Reversion Rates of Tuberculosis Screening Assays in Patients With Rheumatic Diseases and Negative Baseline Screening Under Long-Term Biologic Treatment

BACKGROUND: To determine the conversion and reversion rates of tuberculosis (TB) screening tests (Tuberculin Skin Test-TST, Interferon Gamma Release Assay-IGRA: T-SPOT.TB) during biologic treatment in patients with rheumatic diseases and negative baseline screening. METHODS: This was a long-term, lo...

Descripción completa

Detalles Bibliográficos
Autores principales: Thomas, Konstantinos, Hadziyannis, Emilia, Hatzara, Chrisoula, Makris, Anastasia, Tsalapaki, Christina, Lazarini, Argyro, Klavdianou, Kalliopi, Antonatou, Katerina, Koutsianas, Christos, Vassilopoulos, Dimitrios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Pathogens and Immunity 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7104555/
https://www.ncbi.nlm.nih.gov/pubmed/32258853
http://dx.doi.org/10.20411/pai.v5i1.349

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7104555/
https://www.ncbi.nlm.nih.gov/pubmed/32258853
http://dx.doi.org/10.20411/pai.v5i1.349

Ejemplares similares